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Abstract: From  the first to use of “pseudotumor cerebri” by Nonne in 1904, the historic 
evolution of the knowledge on pseudotumor cerebri has been marked by several periods 
(the otologic stage, the neurosurgical stage, the neuro-ophthalmologic stage); today there 
are clear diagnosis criteria for the idiopathic intracranial hypertension, there is a clear 
differentiation between idiopathic intracranial hypertension and vascular intracranial 
hypertension, also the comprehension of the illness pathogeny is based on the dynamics 
of the intracranial fluids, which allows the auto-regulation of the cerebral circulation 
within quasi-normal limits, despite the very high intracranial pressure. 
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Vascular intracranial hypertension 
Intracranial hypertension can occur in 
cerebral-vascular illnesses due to sanguine, 
cerebral or extra-cerebral, circulatory 
disorders, which modify the dynamics of the 
intracranial fluids and cause the intracranial 
pressure increase. There are disorders in the 
auto-regulation of the cerebral hemodynamics 
and the cerebral parenchyma volume 
continues to increase due to the brain edema 
or to the increase in the cerebral sanguine 
volume (brain swelling) with the secondary 
increase in the intracranial pressure.  
The volume of the cerebral parenchyma 
increases due to the modifications occurred at 
the level of the cerebral sanguine capillaries, 
which leads to:  
- the occurrence of the extracellular brain 
edema due to the increased quantity of 
interstitial fluid:  
- extracellular edema produced by a 
hydrostatic mechanism (ultra-filtration) in 
severe arterial hypertension,  
- extracellular edema with oncotic 
induction (vasogenic edema) due to an 
increased permeability of the brain blood 
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barrier (open brain-blood barrier)  
- cerebral congestive edematization with an 
increase in the volume of the cerebral 
parenchyma by vascular dilatation.  
The vascular types of intracranial 
hypertension have characteristic etiologies 
and they occur by:  
- slowing down or decreasing the 
intracranial venous flux in thrombophlebites 
and cerebral venous thrombosis, the decrease 
in the venous flux at the level of the superior 
longitudinal sinus (SLS) directly in 
compressive lesions (hollowing fracture, etc.) 
or in SLS shunting by an intracranial arterial-
venous malformation, or the extra-cranial 
illnesses that block the returning venous 
circulation at the cervical level, reduce the 
cerebral venous drainage and cause the 
decrease in the absorption of the cranial-spinal 
fluid and then the occurrence of the brain 
edema.   
- in hypertensive encephalopathy, when 
the hydrostatic brain edema occurs (by ultra-
filtration), as well as a brain swelling (by 
vasodilatation).   
- the cerebral ischemia or the ischemic 
stroke reduces the arterial sanguine 
contribution and causes an ischemic brain 
edema, which is a mixed brain edema, both a 
cellular edema (cytotoxic) and an extracellular 
brain edema with oncotic induction 
(vasogenic). 
Cerebral venous thrombosis   
Cerebral venous thrombosis reduce the 
returning venous circulation from the brain 
and the skull, a venous stasis is produced and 
the cerebral sanguine circulation is slowed 
down. There are areas of cerebral hypo-
anorexia concomitantly to areas of venous 
congestive edematization, and the cellular 
cerebral (cytotoxic) edema occurs, as well as 
the oncotic extracellular (vasogenic) edema, 
which evolves to a mixed brain edema. The 
venous sinuses also ensure the resorption of 
the cerebrospinal fluid, and the thrombosis of 
the venous sinuses leads to a diminished 
drainage of the cerebrospinal fluid. Therefore, 
a progressive intra-ventricular accumulation 
of cerebrospinal fluid occurs, with a pressure 
increase in the ventricular system and the 
occurrence of the hydrocephalic brain edema. 
These phenomena happen slowly, in varied 
successions, but the evolution is progressive 
towards an intracranial pressure increase.  
The iatrogenic thrombosis of the internal 
jugular veins is quoted in cases of prolonged 
use of the jugular catheters for the intravenous 
administration of medication. In such cases, 
the same pathogenic processes occur, and the 
ICH syndrome may appear.  
The symptomatology is caused by the 
initial causal lesion, after which neurological 
focal symptoms may occur related to the 
progression of the venous thrombosis, as well 
as symptoms caused by the intracranial 
pressure increase. A venous infarct often 
happens, which is associated to a cerebral 
hemorrhage, which also aggravates the 
neurological clinical presentation.  
Usually, the clinic evolves to an incomplete 
or complete syndrome of intracranial 
hypertension.  
The main characteristics of the intracranial 
pressure increase in cerebral venous 
thrombosis are:  
- a slow increase in the intracranial 
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pressure up to the normal limit value of 20 mm 
Hg, usually during a period of a few days,  
- over the value of 20 mm Hg, the ICP 
increase continues to be progressive, and it 
may reach maximum values of approximately 
30 mm Hg in a few hours or days.   
This gradual increase allows the 
compensating mechanisms to act more 
efficiently, and also for the applied therapy to 
encourage the intracranial pressure decrease 
and the improvement of the cerebral sanguine 
circulation.  
- the maximum values that may be reached 
in cases of intracranial hypertension syndrome 
are of approximately 30- 35 mm Hg 
(sometimes the maximum values may be of 40 
mm Hg) and  
- the pathological pressure values may last 
for several weeks, with a slow return to normal 
pressure values and period of intermittent 
increases,   
- usually, there is a recurrence to 
intracranial pressure values of about and 
above 20 mm Hg, which causes the persistency 
of a prolonged attenuated symptomatology.  
The treatment of the venous thrombosis 
with an ICH syndrome is:  
- etiological and pathogenic for the 
vascular disorder, when possible,  
- pathogenic for the intracranial 
hypertension syndrome.  
A particular pathogenic mechanism is the 
reduction of the venous flux at the level of the 
superior longitudinal sinus (SLS) with an 
important blockage of the CSF resorption:  
- in the case of arterial-venous 
malformations of the Galien vein (Galien vein 
aneurisms), when there is a SLS shunting by 
malformation and the cerebrospinal fluid 
resorption is diminished by the occurrence of 
the hydrocephalus. In infants and small 
children, the dominating symptomatology is 
the cardiac disorder due to the increased 
venous return, while the ICH syndrome also 
occurs in older children.  
- in the case of a median intrusive cranial 
fracture, which interests the third posterior 
part of the SLS.  
- in children with craniostenoses, there 
may be anomalies of the venous drainage, 
which interests the sigmoid sinus and the 
jugular vein, which may cause a venous 
hypertension, with a diminished drainage of 
the cerebrospinal fluid and the increase in the 
intracranial pressure. Usually, the 
phenomenon occurs up to the age of 6 years 
old, after which a collateral venous drainage is 
developed by the stylomastoid plexus, leading 
to the normalization of the intracranial 
pressure. 
Hypertensive encephalopathy  
High blood pressure is the most important 
predisposing factor for cerebral-vascular 
illnesses, and the most frequent complication 
is the cerebral hemorrhage. The exaggerated 
increase in the values of the systemic blood 
pressure also causes disorders of the cerebral 
circulation auto-regulation, with other 
secondary cerebral suffering.  
Hypertensive encephalopathy is defined in 
the clinical presentation of induced 
intracranial hypertension by an acute episode 
of arterial hypertension.  
1. The acute hypertensive encephalopathy 
is caused by the acute blood pressure increase 
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- severe high blood pressure,  
- uncontrolled / untreated high blood 
pressurein pregnancy (eclampsia),  
- high blood pressure in 
glomerulonephritis, pheochromocytoma, etc.  
The acute increase in the sanguine pressure 
values leads to the inefficiency of the cerebral 
vascular auto-regulation, a generalized 
cerebral vascular dilatation occurs and / or 
there is an increased permeability of the 
cerebral capillaries. The increased 
permeability in the brain blood barrier has 
been constant more frequently at the level of 
the gray matter.  
Therefore, the increase in the volume of the 
cerebral parenchyma is caused by:  
- brain swelling by vasodilatation,   
- hydrostatic extracellular brain edema, by 
ultra-filtration when the brain blood barrier is 
intact (close brain-blood barrier)   
- oncotic (vasogenic) extracellular brain 
edema by an injury of the brain blood barrier 
(open brain-blood barrier).  
The posterior reversible encephalopathy 
syndrome (PRES) or the reversible posterior 
leuco-encephalopathy syndrome (RPLS) with 
a hypertensive etiology is included in the acute 
form of vascular etiopathogeny ICH. The 
clinical presentationis typical and the DWI 
exploration shows an extracellular brain 
edema by the increase in the water mobility 
with a posterior bilateral location, and a sub-
cortical interest in the white matter too. The 
treatment consists of decreasing the systemic 
blood pressure.  
2. The chronic hypertensive 
encephalopathy (Binswanger encephalopathy) 
is a rare cerebral-vascular illness with a 
chronic extracellular brain edema: hydrostatic 
brain edema combined with the oncotic brain 
edema.  
The intracranial pressure increase in acute 
hypertensive encephalopathies are 
characterized by:  
- the relatively high speed with which the 
intracranial pressure reaches the normal 
threshold value in approximately a few hours   
- the ICP continues to increase above the 
normal values for a period that is usually 
shorter than the previous interval, of few hours 
only   
- the maximum values that the ICP may 
reach are of 30 – 50 mm Hg and  
- the period with pathologic intracranial 
pressure values is usually of several hours, 
rarely of several days.   The anti-hypertensive 
treatment improves the clinical condition.    
   The unmonitored hypertensive patients, 
or those who are incompletely treated may 
present repeated episodes of hypertensive 
encephalopathy, or they may suffer from the 
most frequent complication, which is the 
cerebral hemorrhage.   
The clinical evolution of hypertensive 
encephalopathy is up to an incomplete 
syndrome of intracranial hypertension, and it 
has a regressive aspect. In the pathogeny of the 
syndrome, there is an auto-limiting 
mechanism: the intracranial pressure increase 
caused by the increase in the sanguine blood 
pressure and by occurrence of the cerebral 
vasodilatation generated the collapse of the 
walls of the intracranial sanguine vessels, and, 
to a certain extent, to a diminished cerebral 
sanguine volume. The mechanism consists of 
the direct action of the increased intracranial 
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pressure over a functional disorder that is 
secondary to the exceeded auto-regulation of 
the cerebral circulation, and it has a limited 
value.  
The treatment of the hypertensive 
encephalopathy is both etiologic and 
pathogenic:   
- the treatment of the hypertensive episode, 
as an etiologic aspect, and  
- the pathogenic treatment of the 
intracranial hypertension syndrome. 
Ischaemic stroke   
   The ischemic stroke represents 85 % of 
the cerebral-vascular illnesses. The large 
ischemic cerebral lesions are accompanied by 
the brain edema with cerebral herniation (sub-
falciform) and by the intracranial pressure 
increase.   
The extended cerebral ischemic infarct 
with phenomena of intracranial hypertension 
is caused by the occlusion or stenosis of a great 
cerebral artery: the internal carotid artery or a 
terminal branch that irrigates a vast territory, 
such as the middle cerebral artery. The 
extended ischemic infarct of the Sylvian artery 
occurs in approximately 10 % of the patients 
with acute cerebral circulatory insufficiency, 
and it has been designated as the malign 
infarct of the Sylvian artery due to the 
increased mortality, of up to 80 % of cases, 
despite the therapeutic means used. The 
massive cerebellum ischemic infarct can cause 
the collapse of the 4th ventricle with the 
occurrence of an acute obstructive 
hydrocephalus and an acute ICH syndrome, 
and it has a direct compressive effect on the 
brainstem with the manifestation of vegetative 
disorders.  
In the case of the cerebral hemispheric 
ischemic stroke, the decreased sanguine flow 
in the territory of the middle cerebral artery 
leads to the occurrence of certain ischemic 
metabolic disorders at the level of the affected 
cerebral parenchyma. The permeability of the 
cerebral capillaries increases (open brain-
blood barrier) and the extracellular oncotic 
(vasogenic) edema occurs. The evolution is 
usually a rapid one, with the extension of the 
brain edema, the increase in the intracranial 
pressure and the occurrence of the sub-
falciform cerebral hernia (median line 
movement towards the unaffected cerebral 
hemisphere). Although the intracranial 
pressure increasing mechanism is based on the 
cerebral ischemia with a hypoxic brain edema, 
which is characteristic for the parenchymatous 
lesions, while the etiology is represented by the 
impacts on a great cerebral artery, and it 
includes the ischemic stroke on vascular 
intracranial hypertension.  
Since the moment of the arterial occlusion, 
the intracranial pressure increase is:  
- rapid until it reaches the normal pressure 
limit of 20 mm Hg, by the progression of the 
brain edema and the surpassing of the pressure 
compensating possibilities, with a duration of 
up to several hours   
- above the normal pressure values, the ICP 
increase is also a rapid one, and the maximum 
values are reached within a short interval of 
time: half an hour – several hours   
- the maximum values of the intracranial 
pressure are of approximately 40 – 50 mm Hg 
and  
- the duration of these pathological values 
is of several days and it corresponds to the 
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intensive care period.    
  The evolution is rapid towards the 
decompensation of the intracranial 
hypertension with almost 80% unfavorable 
results despite the applied treatments. There is 
an attempt in using the etiological treatment of 
the arterial obstruction and the pathogenic 
treatment for the ICH syndrome. During the 
first three hours from the beginning, there may 
be an intravenous administration of 
recombined tissue plasminogen activator 
(rtPA) in a dose of 0.9 mg/kg, maximum 90 
mg; the administration of streptokinase or of 
other thrombolytic agents does not have the 
same efficiency as rtPA. The brain edema 
receives a pathogenic treatment with osmotic 
diuretics (mannitol), and hyperventilation if 
there is an imminent decompensation of 
intracranial hypertension and the production 
of a brain herniation etc. 
Sometimes, there is an attempt of a surgical 
intervention:   
- decompressive craniectomy of posterior 
cerebral fosse and of evacuation of a 
cerebellum infarct with a compressive effect 
on the brainstem, perhaps with a ventricular 
drainage,  
- decompressive craniectomy and the 
evacuation of a cerebral hemispheric massive 
infarct, which may diminish the intracranial 
hypertension, but the surviving patients is left 
with major neurological deficits.  
A particular case of generalized cerebral 
ischemia is met in the post-resuscitation 
syndrome when the sanguine flux disorder 
includes the entire brain, with a complete 
ischemia throughout the stroke, followed by 
reperfusion disorders. 
The consequence of this cerebral 
circulatory failure, primary – before and 
during cardiopulmonary resuscitation, and 
secondary ischemic damage, during 
reperfusion is the development of the mixed 
brain edema: both cytotoxic and vasogenic, 
concomitantly to the production of the glial-
neuronal necrosis. The hyperemic reperfusion 
may exacerbate the brain edema.  The mixed 
brain edema accentuates the elevated 
intracranial pressure and it exacerbates the 
brain injury. The treatment is complex and the 
results do not compensate the efforts. 
 
TABLE I 
Etio-pathogenic and evolutionary characteristics of the various forms of vascular ICH 
Cerebral venous thrombosis  Hypertensive encephalopathy   Ischemic stroke   
  Cerebral vascular pathology:  
- thrombosis of dural sinuses   
- thrombosis of cortical veins   
Cerebral vascular pathology: 
- dilatation of cerebral arteries   
  Cerebral vascular pathology:  
- infarct of Sylvian artery   
- massive cerebellum infarct   
  Cerebral blood flow : 
Reduced venous outflow 
Cerebral blood flow : 
Increase arterial inflow   
  Cerebral blood flow : 
Reduced arterial inflow   
     Pathogenesis:  
- venous dilatation; open BBB and 
vasogenic brain edema  
          and 
    Pathogenesis: 
- dilatation of cerebral vessels; closed BBB 
and hydrostatic brain edema, and  
    Pathogenesis:  
- ischemic increased capillary 
permeability ; open BBB and 
vasogenic brain edema  
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- diminished CSF drainage with 
hydrocephalic brain edema  
-increased vascular permeability with 
open BBB and vasogenic brain edema   
 
     ICP increase: 
- slow to the normal limit   
- slow above the normal limit   
 
    ICP increase: 
- rapid to the normal limit  
- slow above the normal limit   
 
     ICP increase:  
- rapid to the normal limit   
- rapid above the normal limit  
Sub-acute and chronic evolution   
Possible decompensation   
Acute and sub-acute evolution  
Rarely decompensation   
Acute evolution   
Usually  decompensation   
Pathogenic treatment   Pathogenic and etiologic treatment  Etiologic and pathogenic treatment,  
Decompressive craniectomy   
 
Idiopathic intracranial hypertension 
Idiopathic intracranial hypertension is a 
syndrome characterized by the intracranial 
pressure increase in the absence of an 
expansive intracranial process, of 
hydrocephalus, of an intracranial infection, of 
dural venous sinus thrombosis, of 
hypertensive encephalopathy and without a 
neurotoxic etiology. The idiopathic 
intracranial hypertension partially 
corresponds to the old designation of 
pseudotumor cerebri; the term of benign 
intracranial hypertension has also been used, 
but it was subsequently dropped as it was 
noticed that the evolution of this illness can be 
accompanied by complications that exclude 
the idea of benignity (visual acuity decrease to 
cecity in some cases).  
This medical condition is described as a 
specific entity in Quincke’s papers from 1893 
and 1897 and then by Nonne in 1904, who is 
the first to use the term of pseudotumor 
cerebri. Various hypotheses are delivered in 
order to explain the causes and the pathogenic 
mechanisms of the illness. 
In 1955, Foley uses the term “benign 
intracranial hypertension”, which is to be used 
for several decades, and he defines this 
syndrome as follows: “prolonged intracranial 
hypertension without ventricular 
modifications, without focal neurological 
signs, without consciousness or intellectual 
disorders, the most important symptoms 
being a moderate cephalea, blurred sight, 
diplopia and sometimes tinnitus. The only 
signs are the papillary edema and the abducens 
paralysis. The cerebrospinal fluid has a normal 
composition. The prognosis is favorable, and 
the symptoms progressively diminish in 
several weeks or months.”     
According to Foley’s classic definition, 
1955, the idiopathic intracranial hypertension 
occurs as a diagnosis that may be established 
only by exclusion; moreover, even in Dandy’s 
diagnosis criteria, modified by Wall, one of the 
diagnosis elements is the non-identification of 
another cause for the intracranial pressure 
increase. The diagnosis of idiopathic 
intracranial hypertension can be given only 
after the intracranial pressure has been 
measured and after a complete neuro-
imagistic exploration.  
The diagnosis criteria of the idiopathic 
intracranial hypertension, which are 
standardized by Friedman and Jacobson, and 
which are currently accepted are:   
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- the pressure of the cerebrospinal fluid is 
higher than 25 cm H2O, that is higher than 18 
- 20 mm Hg (by lumbar manometry 
performed after the CT or MRI exploration), 
the cerebrospinal fluid has a normal 
composition: normal or reduced cerebrospinal 
fluid proteins and normal cellularity,  
- there are symptoms caused by the 
increased intracranial pressure: papillary 
edema, cephalea, with the absence of the 
neurological location signs (the abducens 
paresis is not a focal sign).  
- the cerebral exploration using CT scan or 
MRI reveals normal cranial-cerebral aspects, a 
ventricular system with reduced dimensions 
may also be revealed (with a collapsed aspect) 
– without significance, or an empty sella; 
moreover, there is no clinical or neuro-
imagistic suspicion of an intracranial venous 
sinus thrombosis.   
These criteria limit the diagnosis of 
idiopathic intracranial hypertension to 
patients who have an increased cerebrospinal 
fluid pressure without a noticeable etiology.  
Although it is not a diagnosis criteria, a 
guiding element is the predominance of the 
feminine sex, with a women / men proportion 
of approximately 2-8 / 1, with an interest in the 
age groups 20 - 50 years old, and with the 
maximum incidence in the third decade of age. 
[10, 11, 12, 13]  
Various pathologic conditions can also be 
taken into account, when the idiopathic 
intracranial hypertension occurs more 
frequently: thus the global incidence of the 
idiopathic ICH is considered to be 1 - 2 cases / 
100,000 but, in the case of young and obese 
women, it has been noticed that the incidence 
of idiopathic intracranial hypertension reaches 
19-25 cases / 100,000.  
The idiopathic intracranial hypertension is 
defined by the clinical existence of the 
intracranial hypertension syndrome, with very 
high ICP values and with a papillary edema in 
uncertain etiological conditions and due to 
pathogenic mechanisms that are difficult to 
establish. The term “associated factors” is used 
for the very diverse situations when the 
idiopathic intracranial hypertension occurs, 
without an etiopathogenic relationship.  
The pathological conditions where the 
idiopathic intracranial hypertension occurs 
are numerous:  
- metabolic and endocrine disorders:  
- if the global incidence of intracranial 
hypertension is estimated at 1 - 2/100,000, in 
young and obese women the incidence of 
idiopathic intracranial hypertension reaches 
19 - 25/100,000.  
- hypothyroidism, parathyroid anomalies,   
- hypovitaminosis A;  anemia due to Fe 
deficiency;  system illnesses – lupus 
eritematos;  
- medicines: - nalidixic acid, tetracycline, 
vitamin A, lithium carbonate, etc.,  
In numerous cases, a possible association 
can be determined with various conditions 
that are pathogenically suggestive, with not 
etiological notification; but there are plenty of 
cases when no etio-pathogenic relation can be 
revealed. 
The pathogenic mechanisms are based on 
the dynamics of the intracranial fluids, and 
they correspond to the circuit of the fluids that 
justify the increased pressure of the 
cerebrospinal fluid and allow the maintenance 
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of the cerebral circulatory auto-regulation 
with a normal nervous functioning. 
The dynamics of the intracranial fluids in 
the case of the idiopathic intracranial 
hypertension can include several fluid circuits 
that concord to the brain edema and to the 
increased parenchymatous pressure, which is 
equal to the increased pressure of the 
cerebrospinal fluid, concomitantly to the 
maintenance of the cerebral sanguine 
circulation, which may explain the good 
clinical condition:  
- hyper-production of interstitial fluid with 
increased resorption at the level of the brain 
blood barrier – which explains the increased 
parenchymatous pressure and the hyper-
production of cerebrospinal fluid, which may 
explain the increased pressure of the 
cerebrospinal fluid, with increased resorption 
at the level of the venous sinuses, as well as 
intense and rapid exchanges from the 
interstitial fluid towards the cerebrospinal 
fluid at the level of the ventricular wall, trans-
ependyma, and at the trans-cerebral pial level, 
which explains the pressure equilibrium 
between the cerebral parenchyma – ventricles, 
with a rapid venous drainage; 
- hyper-production of cerebrospinal fluid, 
increased resorption at the level of venous 
sinuses with rapid venous drainage;  
- hyper-production of interstitial fluid by 
modification of the brain-blood barrier, 
normal production of cerebrospinal fluid, but 
with increased exchanges from the interstitial 
fluid towards the trans-ependyma 
cerebrospinal fluid and at the trans-cerebral 
pial level, with a rapid venous drainage.  
The increased production of cerebrospinal 
fluid at the level of the choroid plexuses, and 
then with increased resorption, cannot explain 
the brain edema and the pressure equilibrium 
at the level of the nervous parenchyma – 
ventricular system.  
The brain edema occurs due to the impact 
on the brain-blood barrier, generating an 
increased flux of interstitial fluid, with an 
increase in the intra-parenchymatous 
pressure.  
The maintenance of the cerebral sanguine 
circulation within normal limits imposes the 
decrease in the parenchymatous pressure, 
which can be achieved through an increased 
resorption of the interstitial fluid and / or by 
the trans-ependyma passage in ventricles, and 
a trans-pial passage in the sub-arachnoid 
space. The resulting increased quantity of 
cerebrospinal fluid does not cause a 
ventricular dilatation because an increased 
resorption occurs; the ventricular system is 
usually reduced in volume, which suggests the 
fact that the trans-ependyma fluid circuit is 
predominant for the increase in the volume of 
cerebrospinal fluid, compared to the 
production at the level of the choroid plexuses. 
The increased resorption of the cerebrospinal 
fluid corresponds quantitatively to the trans-
ependyma exchange from the volume 
increased interstitial fluid, ensuring the 
intracranial circuit of fluids.  
The dynamics of the relations intracranial 
pressure – intracranial volume is expressed by 
the circulation of fluids, which allows the 
existence of an increased fluid pressure, 
although this pressure does not act 
significantly on the endocranial structures and 
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on the cerebral circulation, which is 
maintained within normal limits.  
The most probable pathogenic mechanism 
is the impacts on the brain blood barrier of the 
hyper-production of interstitial fluid and an 
extracellular brain edema; the cerebrospinal 
fluid is produced normally; there are increased 
exchanges from the interstitial fluid towards 
the cerebrospinal fluid at the trans-ependyma 
level and at the trans-cerebral pial level; an 
increased resorption of the cerebrospinal fluid 
is produced, and there is a rapid venous efflux.  
The trans-ependyma exchange between the 
interstitial fluid of the edema from the cerebral 
parenchyma towards the cerebrospinal fluid, 
by means of which pressure is equalized, is 
followed by the increased resorption of the 
cerebrospinal fluid, maintaining the cerebral 
circulation, and representing a compensating 
mechanism. This mechanism is efficient and it 
allows the cerebral circulatory auto-regulation 
when there is a progressive injury of the brain-
blood barrier, the interstitial fluid volume 
increases slowly and the brain edema is also 
gradually installed. 
The trans-ependyma and trans-pial circuit 
of the interstitial fluid towards the 
cerebrospinal fluid is the fundamental element 
for this compensating mechanism of pressure 
increase. 
The increase in the intracranial pressure is 
extremely slow, with a chronic aspect. This 
very slow increase in the intracranial pressure 
allows good pressure compensation and an 
almost normal maintenance of the cerebral 
sanguine flux. The pathogenic ICP values are 
very high, of up to 60 - 80 mm Hg, values that 
may be maintained on a plateau for long 
periods.
 
 
Figure 1 - Hydrodynamic model of pathogeny in idiopathic intracranial hypertension 
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This pathogenic mechanism, which is 
based on the compensation of the fluid 
pressure increase by means of a gradual 
accentuation of the trans-ependyma circuit 
functioning and the trans-pial transfer of the 
interstitial fluid towards the cerebrospinal 
fluid, explains:  
- the absence of hydrocephalus despite the 
increased pressure of the cerebrospinal fluid, 
through increased fluid resorption,  
- the small dimensions of the ventricular 
system due to the initially increased pressure 
at the level of the nervous parenchyma, and 
subsequently balanced by the transfer of the 
interstitial fluid towards the cerebrospinal 
fluid,  
- the good clinical condition due to the 
auto-regulation of the cerebral circulation, 
because the increased intracranial pressure has 
a reduced action on the endocranial structures 
in the dynamic conditions of the rapid fluid 
circuit;  
- the brain edema frequently exists due to 
the dysfunction of the brain blood barrier and 
to the existence of an increased quantity of 
interstitial fluid; at the same time, in some 
cases, the brain edema may be reduced or even 
absent because the fluid transfer towards the 
cerebrospinal fluid is sufficiently rapid and 
intense for the brain edema not to be 
significant. 
Treatment: the therapy is applied 
depending on the possible associated factors – 
metabolic and hormonal corrections, 
exclusion of certain medication, etc. A 
symptomatic treatment is applied for 
cephalea, and cerebral anti-edematous 
substances are administered, such as 
dexamethasone, or diuretics (acetazolamide, 
furosemide) in order to decrease the 
intracranial pressure. In some cases of obese 
patients, the weight loss is followed by an 
obvious clinical improvement, and by the 
progressive reduction of the papillary edema. 
Moreover, repeated lumbar punctures and 
lumbar-peritoneal shunting have been used 
with good clinical results. An approximate 
quantity of 30 ml CSF is evacuated by lumbar 
puncture or the cerebrospinal fluid is drained 
until the intracranial pressure, which is 
measured by the lumbar method, is seen to 
have decreased to approximately half of the 
initial value. The lumbar peritoneal shunting 
drains the excessive CSF and the 
symptomatology disappears within less than a 
month; the shunting revising rate may reach to 
50 %. In some cases of significant visual acuity 
decrease, there has been an attempt to 
decompress the optic nerve by performing 
fenestrations at the level of the optic nerve 
sheath in order to produce a decrease of the 
papillary edema, but the results are not always 
favorable. 
Comparison between idiopathic ICH 
and the vascular type of ICH  
The recent literature data and the the above 
presentations allow the differentiation 
between the vascular type of ICH and 
idiopathic ICH. The name hyperemic ICH has 
been suggested but the designation of vascular 
ICH covers the etiology and pathogenesis 
better and more completely. 
Although the symptoms may be similar in 
these two diseases, the imaging findings, 
therapy and evolution are different; therefore, 
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the etiology and pathogenesis are different. 
Vascular ICH has a known etiology, such as 
cerebral vascular illness whereas idiopathic 
ICH has no known etiology or has various 
nonspecific factors associated factors (e.g., 
metabolic and endocrine disorders, 
hypovitaminosis A, and medications). The 
imaging diagnosis for vascular ICH showed a 
cerebral venous sinus thrombosis or stenosis 
or a cerebral venous thrombosis and either 
normal images or small ventricles in idiopathic 
ICH. The imaging diagnosis of idiopathic ICH 
excludes other diseases with similar 
symptoms. 
  Vascular ICH involves vasogenic brain 
edema with papillary edema, whereas 
idiopathic ICH commonly involves papillary 
edema and diminished visual acuity in some 
cases. There is also brain edema in idiopathic 
ICH, but this appears to be balanced by the 
intraventricular pressure. The increase in ICP 
is faster in vascular ICH compared with the 
very slow ICP increase in idiopathic ICH, as 
demonstrated by the longer period until the 
complete clinical syndrome has developed. In 
addition, the ICP values are higher in 
idiopathic ICH. Therefore, the critical ICP 
values are lower in vascular ICH until the 
decompensation of ICH. 
The treatment is symptomatic, as well as 
etiologic and pathogenic in vascular ICH but 
only symptomatic in idiopathic ICH 
(including a lumboperitoneal shunt or 
decompression of the optic nerve). 
Vascular ICH may potentially include 
other syndromes, such as hypertensive 
encephalopathy, but this classification 
requires further study. In hypertensive 
encephalopathy, there is a dilatation of brain 
arteries with increased arterial inflow, 
increased vascular permeability, and 
disruption of the braineblood barrier; brain 
edema occurs as a result. 
   In conclusion, ICH caused by 
intracranial vascular damage is vascular ICH 
and although it has clinical similarities to 
idiopathic ICH, there are important 
differences: vascular ICH has a known 
etiology, such as cerebral vascular illness, and 
the increase in ICP is faster in vascular ICH, 
but the critical ICP values are lower compared 
with idiopathic ICH.  
The therapy is etiologic, pathogenic and 
symptomatic in vascular ICH, but is only 
symptomatic in idiopathic ICH. 
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